We are live on ! Find out more
OFM

Omega Fund Management Portfolio holdings

AUM $186M
1-Year Est. Return 155.23%
This Fund
S&P 500
This Quarter Est. Return
-21.29%
1 Year Est. Return
+155.23%
3 Year Est. Return
+106.31%
5 Year Est. Return
+162.6%
10 Year Est. Return
+764.79%
AUM
$169M
AUM Growth
+$15.3M
Cap. Flow
+$78.3M
Cap. Flow %
46.19%
Top 10 Hldgs %
97.9%
Holding
14
New
2
Increased
–
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
KMTS
Kestra Medical Technologies
KMTS
+$41.3M
2
BBNX
Beta Bionics
BBNX
+$37.1M

Top Sells

Rank Stock Value
1
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
+$57.8K

Sector Composition

Rank Sector Weight
1 Healthcare 99.89%
2 Miscellaneous 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KMTS
1
Kestra Medical Technologies
KMTS
$1.41B
$44.8M 26.41%
+1,795,893
New +$41.3M
BCAX
2
Bicara Therapeutics
BCAX
$1.56B
$28.7M 16.95%
2,204,650
– –
BBNX
3
Beta Bionics
BBNX
$784M
$24.3M 14.36%
+1,988,287
New +$37.1M
NUVB icon
4
Nuvation Bio
NUVB
$2.29B
$23M 13.58%
13,072,340
– –
REPL icon
5
Replimune Group
REPL
$1.36B
$19.3M 11.36%
1,975,203
– –
UPB
6
Upstream Bio Inc
UPB
$326M
$12.5M 7.35%
2,036,293
– –
LXEO icon
7
Lexeo Therapeutics
LXEO
$368M
$4.11M 2.43%
1,184,636
– –
ALMS
8
Alumis Inc
ALMS
$1.27B
$4.01M 2.37%
653,223
– –
IMA
9
ImageneBio Inc
IMA
$56.9M
$2.88M 1.7%
187,427
– –
ENGN icon
10
enGene Therapeutics
ENGN
$124M
$2.36M 1.39%
526,357
– –
IMUX icon
11
Immunic
IMUX
$166M
$1.95M 1.15%
178,816
– –
SANA icon
12
Sana Biotechnology
SANA
$949M
$1.42M 0.84%
843,750
– –
ENGNW icon
13
enGene Therapeutics Warrants
ENGNW
$193K 0.11%
321,502
– –
SYRS
14
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
– –
-251,270
Closed -$57.8K

Similar funds

LBC
Leigh Baldwin & Co Cazenovia, New York $186M AUM 40.09% 1-Year Est. Return
GWCM
Godshalk Welsh Capital Management Radnor, Pennsylvania $186M AUM 18.63% 1-Year Est. Return
FWM
Fingerlakes Wealth Management Ithaca, New York $186M AUM 30.5% 1-Year Est. Return
LOIP
Live Oak Investment Partners Austin, Texas $186M AUM 19.39% 1-Year Est. Return
TFA
Tranquilli Financial Advisor Clinton, New Jersey $186M AUM 18.12% 1-Year Est. Return
NCM
Northland Capital Management Virginia, Minnesota $186M AUM 16.43% 1-Year Est. Return
GPI
General Partner Inc Pittsburgh, Pennsylvania $186M AUM 25.15% 1-Year Est. Return
MWM
Melfa Wealth Management Westborough, Massachusetts $185M AUM 17.73% 1-Year Est. Return

Omega Fund Management's Q1 2025 Portfolio in Review

As of Q1 2025, Omega Fund Management held 14 positions worth $169M, up 9.9% from $154M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Omega Fund Management deployed $78.3M of net new capital in Q1 2025, opening 2 new positions. Its largest new stake was Kestra Medical Technologies: 1,795,893 shares worth $44.8M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier, followed by Miscellaneous.

On the sell side, the most notable exit was Syros Pharmaceuticals, Inc. Common Stock, an estimated $57.8K sold.

  • Omega Fund Management's largest Q1 2025 buy was Kestra Medical Technologies: 1,795,893 shares worth $44.8M.
  • Omega Fund Management fully exited Syros Pharmaceuticals, Inc. Common Stock in Q1 2025, selling an estimated $57.8K.
  • Omega Fund Management's ten largest holdings make up 98% of its $169M portfolio in Q1 2025.
  • Omega Fund Management opened 2 new positions and closed 1 in Q1 2025.
  • Omega Fund Management's portfolio value rose 9.9% quarter-over-quarter to $169M.

Based on Omega Fund Management's 13F filing for Q1 2025, filed 15 May 2025.